
Omada Health
Omada Health (OMDA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
omda · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Omada Health (OMDA) measures how much investors pay for each dollar of the company's trailing earnings. OMDA's current PE ratio of N/A is calculated by dividing its stock price of $17.88 by its TTM earnings per share of -$0.11.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2022 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Omada HealthYou OMDA | $1.1B | N/A | — | -$0.11 |
BioCryst Pharmaceuticals, Inc. BCRX | $1.8B | 6.20x | -98.2% | $1.26 |
Maze Therapeutics, Inc. MAZE | $1.3B | N/A | — | -$3.05 |
Omnicell, Inc. OMCL | $1.9B | 1014.72x | +188.6% | $0.04 |
Progyny, Inc. PGNY | $2.0B | 37.40x | -89.4% | $0.69 |
Phreesia, Inc. PHR | $577M | 347.91x | -1.0% | $0.04 |
Schrödinger, Inc. SDGR | $1.1B | N/A | — | -$1.41 |
Industry Average 4 peers with valid PE | — | 351.56x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.22 | — | |
2024-12-31 FY2024 | — | $-0.85 | — | |
2023-12-31 FY2023 | — | $-1.21 | — | |
2022-12-31 FY2022 | — | $-1.30 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Omada Health (OMDA) measures how much investors pay for each dollar of the company's trailing earnings. OMDA's current PE ratio of N/A is calculated by dividing its stock price of $17.88 by its TTM earnings per share of -$0.11.
Frequently asked questions
OMDA pe ratio · 6 questionsOMDA's current PE ratio is N/A as of 2026-06-09, based on a stock price of $17.88 and TTM EPS of -$0.11. Data sourced from Financial Modeling Prep via OMDA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Omada Health SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09